What is the fair value of Turn Therapeutics Inc (NASDAQ-TTRX) stock?

The current fair value estimate for Turn Therapeutics Inc (NASDAQ-TTRX) is $8.42. This implies an estimated downside of 45.0% versus the current market price.

Is Turn Therapeutics Inc (NASDAQ-TTRX) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 45.0% versus the current market price.

What is the analyst price target for NASDAQ-TTRX stock?

The available analyst price target for Turn Therapeutics Inc (NASDAQ-TTRX) is $26. The analyst target implies estimated upside of 70.0%.

How is the financial health of Turn Therapeutics Inc?

The current financial health read for Turn Therapeutics Inc (NASDAQ-TTRX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Turn Therapeutics Inc's next earnings date?

The next earnings date currently listed for Turn Therapeutics Inc (NASDAQ-TTRX) is November 12, 2026.

Does Turn Therapeutics Inc (NASDAQ-TTRX) pay dividends?

The latest available data indicates no current dividend yield for Turn Therapeutics Inc (NASDAQ-TTRX).

What is the market capitalization of Turn Therapeutics Inc?

The current market capitalization listed for Turn Therapeutics Inc is 455.5 M.

What is the enterprise value of Turn Therapeutics Inc?

The current enterprise value listed for Turn Therapeutics Inc is 452.8 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Turn Therapeutics Inc?

The ticker symbol for Turn Therapeutics Inc is NASDAQ-TTRX, and the stock is listed on NASDAQ.

Where is Turn Therapeutics Inc (NASDAQ-TTRX) listed?

Turn Therapeutics Inc (NASDAQ-TTRX) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Turn Therapeutics Inc?

The current debt-to-total-capital ratio listed for Turn Therapeutics Inc is 1.3%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Turn Therapeutics Inc?

The free float listed for Turn Therapeutics Inc is 36.4%. Free float helps investors understand how much of the share base is available for public trading.

Turn Therapeutics Inc (TTRX) Fair Value & Stock Analysis |...

Turn Therapeutics Inc (TTRX)

Turn Therapeutics Inc. is a NASDAQ-listed common stock issuer in the healthcare sector, focused on pharmaceuticals. The company develops therapies for diseases affecting the skin, nails, and eyes, and its delivery technology is designed to penetrate skin and nails while also supporting acute and chronic wound care applications. Turn Therapeutics says this platform is intended to help healthcare institutions manage a range of conditions, including wounds, broader skin disorders, and dermatoses, while also addressing antibiotic resistance concerns. The company was incorporated in 2015 and is based in Westlake Village, California. It was previously known as Global Health Solutions, Inc. before adopting the Turn Therapeutics Inc. name in September 2025.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Book Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
NASDAQ-TTRX	$8.42	-45.0% Downside	Overvalued	$26	70.0% Upside	Bargain	Fair	0.0%	November 12, 2026	665.2x	455.5 M	452.8 M	1.3%	36.4%	12.8	51.2%